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1. Introduction
Infectious disease is one of the main complications in the patients on long-term hemodialysis.
Various clinical features, including multiple comorbidities, frequent hospitalization, and
immunosuppression, rendered these patients susceptible to nosocomial infections. Further‐
more, hemodialysis frequently results in chronic wasting, inflammation, uremia and gastro‐
intestinal disturbances, all of which contribute to the increasing frailty of the patient. In their
weakened state, these patients are susceptible to infectious complications such as aspiration
pneumonia. In this section, we discuss these aspects of hemodialysis based on the recent our
clinical observations.
1.1. Background of infectious disease in maintenance hemodialysis patients
Infectious diseases are significant causes of morbidity and mortality among patients with end-
stage renal disease (ESRD), which is ranked as the second leading cause of death in Japanese
maintenance hemodialysis (MHD) patients, following cardiovascular diseases. An increased
susceptibility to infections has been ascribed partly to old age, a high prevalence of diabetes,
defective phagocytic function of granulocytes, and frequent exposure to potential infectious
risk factors during the hemodialysis therapy including endotoxin [1]. Anemia and malnutri‐
tion also contribute to the immune-compromised status of MHD patients. In addition, MHD
patients are suffering from protein-energy wasting (PEW), making them susceptible to
sarcopenia due to increased muscle protein degradation. Malnutrition causes impaired
immune function and poor wound healing.
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In addition, MHD patients usually have problems other than infections, such as cardiovascular
or muscle-skeletal disorders. These patients are frequently hospitalized for surgical proce‐
dures or reasons other than infection, where they were treated with various kinds of antibiotics
over a long period. These typical clinical courses undergone by MHD patients are known to
influence the clinical characteristics and microbiological features of pneumonia.
2. PEW and Frailty in MHD patients
As MHD patients get older, they are affected more severely by age-related problems as
compared to their counterparts in the general population. Two of the most significant problem
are frailty and protein energy wasting (PEW) [2]. This phenomenon is clinically relevant
because many manifestations of frailty and PEW are strong risk factors that affect quality of
life, morbidity, and mortality. Frailty can be defined as a biological syndrome of decreased
resistance to stressors caused by cumulative declines across multiple physiological systems
which, ultimately, results in vulnerability to adverse outcomes. Frailty implies decreased body
energy, protein reserves and reduced strength. Frailty is a common occurrence in CKD as well
as MHD patients. A simple criterion for frailty can be the presence of three or more of the
following abnormalities; unintentional weight loss, self-reported exhaustion, measured
weakness, slow walking speed, and low physical activity. On the other hand, PEW is defined
as the loss of somatic and circulating body protein and energy reserves. The comorbidity of
infectious disease is also subject to the influence of these conditions. For instance, sarcopenia
and osteopenia puts the patient at risk for falls as well as contracting pneumonia. In regards
to aspiration pneumonia (AP), sarcopenia often causes difficulty in swallowing, which leads
to unrecognized aspiration. Coordinated muscle movement and optimal muscle strength play
an important role in the well-organized swallowing movement. Aspiration status was partly
dependent on the lower anterior and posterior esophageal muscle and tongue strength [3].
These muscle strength was imparired by the decline in the global physical status. In ESRD
patients under MHD, muscle and energy wasting are prominent, which influences the
mortality and morbidity [2]. The tissue changes in muscle varies from morphological, electro‐
physiological and metabolic alterations. These malign changes of muscles lead to muscle
weakness and finally to myopathy [4]. Additionally, atrophy of type II fibers was observed in
the patients with MHD in several studies. These functional and structural muscle impairments
in both systemic and/or oropharyngeal muscle strength are derived from the PEW state in
MHD patients. Impaired immune function is associated with PEW in MHD [5]. In addition to
an increased susceptibility to infections and poor wound healing, PEW leads to an impaired
immune function which affects the gastrointestinal tract malfunction and aberrant microbiota
population. These intestinal changes cause malabsorption and malnutrition [6], accelerating
further the immune dysfunction. Deterioration in intestinal structure also leads to the en‐
hancement of bacterial translocation in the intestine, leading to systemic inflammation and
PEW state.
PEW involves several mechanisms, including the activation of oxidative stress, the inflamma‐
tory response, and the dialysis measure itself. Several markers of PEW and the resultant
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malnutrition have been associated with the incidence and death rates in patients with MHD
[2]. Biochemical markers like lower serum albumin, prealbumin and cholesterol levels [7] are
linked to malnutrition with higher fatality in dialysis patients. Serum transferrin, creatinine
and bicarbonates [8] as well as hemoglobin levels, lymphocytes counts and white blood cell
counts are also shown to be associated with malnutrition. We previously reported that serum
creatatinine, albumin and total cholesterol levels are independent risk factors for contracting
AP and its corresponding mortality rate. We also identified serum inorganic phosphorus (IP)
as the main predictors of dietary intake in MHD patients [9]. Since 24-hour creatinine excretion
and serum creatinine levels are associated with muscle mass [10], creatinine decline over time
are related to the level of malnutrition as well as sarcopenic changes after admission [10]. It
was reported that, in a cohort of 121,762 MHD patients, serum creatinine decline, and lower
body mass, lower muscle mass and weight loss are associated with higher mortality in MHD
patients [11]. It was also reported that among these clinical parameters, a decline in serum
creatinine is suggested to be a stronger predictor of fatality than weight loss in MHD patients
[12]. Our study is in consistent with the results of this large cohort study in that creatinine
decline rate as well as albumin decline rate are good predictive indicator for morbidity and
mortality of AP [9].
3. Respiratory infection in hemodialysis
Pneumonia is the second most common cause of severe infection in the MHD population.
Regarding infectious diseases, it has been reported that approximately 20% of infectious deaths
in MHD patients are attributed to pneumonia. The mortality of pulmonary infections in MHD
patients has been reported to be 14 to 16 times higher than in the general population [13].
Streptococcus pneumonia, seasonal influenza and bacterial pneumonia secondary to influenza
have been leading causes for community-acquired pneumonia in MHD. A vaccination is
available for the prevention of pneumonia from Streptococcus pneumonia as is same with the case
in the general population. Current guidelines recommend the vaccination of all MHD patients
and revaccination after 5 years since a more rapid decline in the antibody titer was observed
compared to that of the general population.
4. Nosocomial pneumonia
We surveyed 1803 MHD patients admitted to our university hospital between April 2001 and
March 2007 [14]. We investigated basic patient characteristics and clinical characteristics of
nosocomial pneumonia. The distribution of patient age indicated that about 70% of the patients
were over 60 years old. The average length of hospitalization was 28.1 days, ranging from one
day to 478 days, which was longer than the average for our hospital (14.2 days). Patients were
admitted to different departments for a variety of reasons. We isolated 391 microorganisms
from the sputa of 138 patients that were suspected of respiratory tract infections. These include
Candida albicans (C. albicans), methicillin-resistant Staphyloccocus aureus (MRSA), and Staphy‐
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loccocus epidermidis which were the leading three isolates. Among these patients, 47 were
diagnosed with pneumonia and 57 pathogens were isolated. From the sputa specimen of
pneumonia patients, MRSA and C. albicans were most frequently isolated. Stenotrophomonas
maltophilia (S. maltophilis) was also isolated and found to be resistant to older generation
cephalosporins, carbapenems, and quinolones. However, new fluoroquinolones, such as
levofloxacin, were found to be affective. Among the 138 patients suspected of respiratory tract
infections, 15 out of 23 patients infected with S. maltophilia died, resulting in the highest
mortality among all patients with nosocomial pneumonia examined. With this survey, we
concluded that MHD patients suffered from nosocomial pneumonia with multi-drug resistant
pathogens. Consequently, S. maltophilia-related infections are associated with a high mortality
rate and should be taken very seriously.
5. AP in MHD patients
Of the different types of pneumonia, AP is of particular interest due to its recent increase in
occurrence in the aged MHD population. Aged patients are susceptible to dysphagia caused
by neurological dysfunctions due to cerebral infarctions, cognitive deficits, and muscle
weakness. Since HD patients are susceptible to sarcopenia and malnutrition, these changes
increases the risk of development of AP. We recently reported on the clinical characteristics of
AP in MHD patients [9]. We surveyed consecutive MHD patients with nosocomial AP who
were admitted to our university hospital between April 2007 and December 2008. We deter‐
mined hospitalized MHD patients as a high-risk population for AP, and we revealed that the
mortality rate of HD patients with AP was high. We analyzed the risk factors for AP and found
that the rate of decline of serum creatinine and albumin levels indicative of the decrease in
muscle mass and malnutrition were of predictive value for the contraction of AP. We also
found that he AP patients fed via nasal tube feeding or oral intake tended to survive.
6. Management of nosocomial pneumonia
Based on the clinical backgrounds, MHD patients suffered from nosocomial pneumonia with
multi-drug resistant pathogens. Significantly, we reported that S. maltophilia-related infections
should be taken seriously due to the associated high mortality rate. In addition, we stressed
the clinical importance of AP for MHD patients suffering from PEW. Various treatment options
to prevent AP were advocated, including oral hygiene, altered food viscosity, and positioning
[9]. Medications for this purpose include angiotensin-converting enzyme inhibitors and
amantadine. In our study, early initiation of tube feeding appears to provide more favorable
outcomes in light of intestinal conditions or fluid restrictions in HD patients. Parenteral
nutrition directly affects the total body fluid volume and is prone to volume overload as
compared to tube feeding. In addition, malnutrition and sarcopenia lead to silent aspiration
where the symptoms are not always clinically evident. Since hospitalized patients with
hemodialysis often progress to a state of malnutrition, the patients should be considered to
have silent aspiration and treated with tube feeding.
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7. Conclusions
Various backgrounds including multiple comorbidities, PEW or frailty, impaired immune
response, infectious diseases and pneumonia were prevalent in MHD patients. Our surveil‐
lance revealed that MHD patients suffered from nosocomial pneumonia with multi-drug
resistant pathogens. S. maltophilia-related infections should be very seriously in light of the
associated high mortality rate. Based on the PEW condition, both the contraction and mortality
rates of nosocomial AP were high among HD patients.
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